Mikhail Blagosklonny: The Oncological Researcher Making Notable Discoveries In The Field Of Medicine

Mikhail Blagosklonny is someone who has been an extremely big boon to the field of cancer. He is known to be one of the most prominent cancer researchers today, and has drafted some of the most landmark advancements in the field of oncology. Mikhail Blagosklonny has been working as a researcher for an extremely long period of time. He has been researching and trying to find a more effective treatment for this disease that claims numerous lives all over the world. This need to reform the current treatment came to him after a thorough analysis of the effect that the current methodology works on the patients who are diagnosed with cancer. Read more on templeofthecave.com

Mikhail Blagosklonny started working in the field of oncological research soon after he passed out of medical school. He realized that he wanted to enter into research soon after he joined medical school. He had a goal in mind which he wanted to pursue, and through hard work and dedication has gotten to the top of his field. With the idea of research in mind soon after finishing medical school, he began working with Ordway, a company that was dedicated to researching the field of oncology. Orway was a brilliant fit for Mikhail Blagosklonny, because it resonated with everything that he wanted from a professional career at that time. He made some brilliant progress while working in the field of cancer research, which has impacted the way doctors treat their patients. His research was mainly focused at finding viable ways for the elimination of cancer cells.

Mikhail Blagosklonny has always possessed a keen interest in learning and believes in imparting all the knowledge that he possesses. In his early days, Mikhail Blagosklonny used to be a professor at New York Medical College. He was one of the most renowned professors at the university and had numerous students looking up to him while he taught there. Currently, Mikhail Blagosklonny teaches at the Roswell Park Cancer Institute. He is the head of the oncology department at the institute. Being as experienced as he is in the field, he has impacted the lives of numerous students by giving them the valuable knowledge that they wouldn’t get elsewhere.

One of the most notable achievements that Mikhail Blagosklonny has conducted during his time as a researcher was the discovery of a property within cancer treatment drugs, that could help improve the life expectancy of those who don’t have cancer. This discovery was extremely remarkable not just in the field of oncology, but in the medical profession as a whole. Till date, there have been very few leads that can improve the expectancy of human life, with even less research done on the subject. The discovery was made when Mikhail Blagosklonny was conducting his research on the current treatments that are being used to treat patients. He soon noticed that a certain chemical known as Rapamycin was helping in improving the life expectancy. Finding something that can provide this utility in human life would not only help people in this generation, but in the following to come. Read more about Mikhail at LinkedIn.com

Omar Boraie Chair at Rutgers Cancer Institute

On November 2015, Rutgers Cancer Institute established the Omar Boraie Chair in Genomic Science, reports Patch.com. The reason was to facilitate precision medicine research. At higher education level, an endowed chair is considered the gold standard which shows the institute’s commitment to a particular academic discipline. Omar Boraie is a real estate developer who is famous for his work in Brunswick. To support Genomic Science research at the cancer institute, he has donated a huge amount of one-and-half million dollars. Rutgers University has an eighteen chair campaign in which each donor provides one-and-half million dollars. The chair named after Boraie is one of them. One can find the details of this information at Newswire.

The fields like Genomic Science and Precision Medicine are rapidly changing in the modern era. As a result, the scientists and medical researchers are forced to change their methods for the diagnosis and treatment of cancer. It is about analyzing and treating the tumor. The new approach enables oncologists to provide better results through tailored therapies. Even former US President Barack Obama mentioned in his State of the Union Address that an initiative for precision medicine would be launched on a national level. It would focus on the treatment of many diseases including cancer. Several centers are trying to find a cure for cancer by using gene sequencing. Rutgers Cancer Institute is the first one to use genomic sequencing.

There are some cancer problems that do not have effective treatments. Genomic sequencing is necessary to find therapies for such problems. At the same time, precision medicine is categorizing the sub-categories of different types of cancers based on similar characteristics but separate genetics. The process facilitates to bring better results, and doctors can proceed with individualized cancer therapies.

Omar Boraie expressed his views about the work being done by the physicians and scientists at Rutgers Cancer Institute. He said that they are doing a good job in precision medicine which would help patients with unusual cancers. It will be a very good thing if all cancer patients can benefit from this advancement. Boraie’s pledge is to support this important work that can bring unexpected results. He added that his family’s pledge would also encourage other people to support this important work. Robert S. DiPaola, Director Rutgers Cancer Institute, said that Boraie is working on developing a healthcare city in New Brunswick, https://local.yahoo.com/info-11014537-boraie-realty-new-brunswick. It is expected that there will be a significant advancement in Genomic Science due to Omar Boraie’s support.

Source: crunchbase.com